Q-marker identification strategies in traditional Chinese medicines: a systematic review of research from 2020 to 2024
Frontiers in Medicine · 16.01.2026 · 12
DOI: 10.3389/fmed.2025.1709969 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Medicine, online erschienen am 16.01.2026. Verfasst von Khoa Nguyen Tran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Korean Medicine, Dongguk University, Gyeongju, Republic of Korea. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean Health Technology R&D Project of the Korean Ministry of Health and Welfare, National Research Foundation, Dongguk University Research Fund.
Abstract (Originalsprache)
Background
The concept of “quality markers” (Q-markers) has emerged as a key solution to address limitations in the evaluation and standardization of traditional herbal medicines. Despite the introduction of various Q-marker identification strategies, methodological inconsistencies and a lack of standardization continue to pose challenges.
Objectives
This review aims to systematically organize and evaluate Q-marker selection strategies published over the past 5 years and propose an optimal approach based on a comparative analysis of their strengths and limitations.
Methods
A comprehensive literature search was performed on the Web of Science and PubMed for studies published between January 2020 and December 2024 using keywords related to Q-marker identification in traditional prescriptions. After removing duplicates and screening for relevance, the eligible studies were systematically reviewed. Key information, including the prescription name, therapeutic targets, methodological steps for Q-marker selection, and the final identified Q-markers, was extracted and organized into summary tables. Based on the analysis, the advantages and limitations of each strategy were evaluated.
Results
The studies were categorized into four representative strategies: [S1] mechanism-driven validation, which relies on network pharmacology and bioassays to align compounds with disease pathways (22 cases, 36.67%); [S2] profile–effect correlation modeling, which uses statistical and machine learning tools to link chemical composition with pharmacodynamic outcomes (24 cases, 40%); [S3] in silico preliminary filtering, which rapidly screens candidate compounds using computational predictions without experimental validation (8 cases, 13.33%); and [S4] multi-criteria decision frameworks, which integrate formulation hierarchy, efficacy, and chemical properties into composite scoring models (6 cases, 10.00%). The average number of Q-markers identified in each strategy was 7.23, 6.61, 8.25, and 7.5, respectively. While each strategy has unique analytical strengths, they often lack consistency and reproducibility when applied in isolation. To overcome this, we recommend a stepwise approach that integrates (1) compound selection based on bioavailability, (2) disease-relevant biomarker selection, (3) correlation modeling, and (4) a multi-criteria scoring framework based on TCM principles. This integrated model accounts for compound bioavailability, specificity, and formulation roles, enabling the identification of functionally relevant Q-markers, including low-abundance constituents.
Conclusion
This review can provide valuable insights to guide future research and development of traditional herbal medicines, particularly in the context of quality control and innovative drug discovery. The proposed framework improves biological relevance and practical applicability and may serve as a scalable model for the quality assessment of multi-component herbal systems and complex pharmacological formulations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, College of Korean Medicine, Dongguk University, Gyeongju, Republic of Korea.
Förderung
- Korean Health Technology R&D Project of the Korean Ministry of Health and Welfare
- National Research Foundation
- Dongguk University Research Fund
Zitieren
APA
Tran, K. N., Mac, G. L., Munni, Y. A., & Yang, I. J. (2026). Q-marker identification strategies in traditional Chinese medicines: a systematic review of research from 2020 to 2024. Frontiers in Medicine, 12. https://doi.org/10.3389/fmed.2025.1709969
Vancouver
Tran KN, Mac GL, Munni YA, Yang IJ. Q-marker identification strategies in traditional Chinese medicines: a systematic review of research from 2020 to 2024. Frontiers in Medicine. 2026;12. doi:10.3389/fmed.2025.1709969
BibTeX
@article{Tran2026,
author = {Tran, Khoa Nguyen and Mac, Gia Linh and Munni, Yeasmin Akter and Yang, In-Jun},
title = {Q-marker identification strategies in traditional Chinese medicines: a systematic review of research from 2020 to 2024},
journal = {Frontiers in Medicine},
year = {2026},
volume = {12},
doi = {10.3389/fmed.2025.1709969}
}
EUVIMED